New #TheLancetNeuro paper: Safety and efficacy of delpacibart zotadirsen in Duchenne muscular dystrophy mutations amenable to exon 44 skipping in the USA (EXPLORE44): a randomised, placebo-controlled, double-blind, phase 1/2 trial. #DMD #Myoblue tinyurl.com/5n7vxnnx